Literature DB >> 9988731

Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks nuclear localization sequence-dependent nuclear protein import.

L G Yu1, D G Fernig, M R White, D G Spiller, P Appleton, R C Evans, I Grierson, J A Smith, H Davies, O V Gerasimenko, O H Petersen, J D Milton, J M Rhodes.   

Abstract

The Galbeta1-3GalNAcalpha (TF antigen)-binding lectin (ABL) from the common edible mushroom (Agaricus bisporus) has a potent anti-proliferative effect without any apparent cytotoxicity. This unusual combination of properties prompted investigation of its mechanism of action. In contrast to soluble lectin, agarose-immobilized, and hence noninternalizable ABL had no effect on proliferation of HT29 colon cancer cells. Electron microscopy of HT29 cells incubated with fluorescein- and gold-conjugated ABL showed internalization of the lectin into endocytotic vesicles and multivesicular bodies. Confocal microscopy showed perinuclear accumulation of fluorescein isothiocyanate-conjugated lectin, which also inhibits HT29 cell proliferation, raising the possibility that the lectin might interfere with nuclear pore function. Transport of heat shock protein 70 into the nucleus in response to heat shock was blocked by preincubation of HT29 cells for 6 h with 40 micrograms/ml ABL. In digitonin-permeabilized cells, nuclear uptake of bovine albumin conjugated to a nuclear localization sequence (NLS)-containing peptide was also inhibited by a 15-min preincubation with 40-100 micrograms/ml ABL. In contrast, serum-stimulated nuclear translocation of mitogen-activated protein kinase, which is NLS-independent, was not affected by pretreatment of cells with the lectin. These results suggest that the anti-proliferative effect of ABL is likely to be a consequence of the lectin trafficking to the nuclear periphery, where it blocks NLS-dependent protein uptake into the nucleus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988731     DOI: 10.1074/jbc.274.8.4890

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Genetically modified foods and the Pusztai affair.

Authors:  J M Rhodes
Journal:  BMJ       Date:  1999-05-08

2.  Effect of polyvalencies of glycotopes on the binding of a lectin from the edible mushroom, Agaricus bisporus.

Authors:  Albert M Wu; June H Wu; Anthony Herp; Jia-Hau Liu
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

3.  Stress-induced phosphorylation of caveolin-1 and p38, and down-regulation of EGFr and ERK by the dietary lectin jacalin in two human carcinoma cell lines.

Authors:  Anagh A Sahasrabuddhe; Neesar Ahmed; M V Krishnasastry
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

4.  Dietary lectins can stimulate pancreatic growth in the rat.

Authors:  Angela Kelsall; A J FitzGerald; C V Howard; R C Evans; R Singh; J M Rhodes; R A Goodlad
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

5.  Sustained mitogenic effect on K562 human chronic myelogenous leukemia cells by dietary lectin, jacalin.

Authors:  V Lavanya; Neesar Ahmed; Md Khurshid Alam Khan; Shazia Jamal
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

6.  A potent mitogenic lectin from the mycelia of a phytopathogenic fungus, Rhizoctonia bataticola, with complex sugar specificity and cytotoxic effect on human ovarian cancer cells.

Authors:  Nagaraja N Nagre; Vishwanath B Chachadi; Palaniswamy M Sundaram; Ramachandra S Naik; Radha Pujari; Padma Shastry; Bale M Swamy; Shashikala R Inamdar
Journal:  Glycoconj J       Date:  2010-03-22       Impact factor: 2.916

Review 7.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

8.  An antitumour lectin from the edible mushroom Agrocybe aegerita.

Authors:  Chenguang Zhao; Hui Sun; Xin Tong; Yipeng Qi
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

9.  Modulation of PP2A activity by Jacalin: is it through caveolae and ER chaperones?

Authors:  Neesar Ahmed; Satyabrata Pany; Aejazur Rahman; Saumya S Srivastava; Amita Sneh; Musti V Krishnasastry
Journal:  Glycoconj J       Date:  2009-10-13       Impact factor: 2.916

Review 10.  Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.

Authors:  B J Campbell; L G Yu; J M Rhodes
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.